{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T17:33:07Z","timestamp":1794677587261,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH117431"],"award-info":[{"award-number":["R01MH117431"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["2I01CX000139"],"award-info":[{"award-number":["2I01CX000139"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anxiety disorders are increasingly prevalent, affect people\u2019s ability to do things, and decrease quality of life. Due to lack of objective tests, they are underdiagnosed and sub-optimally treated, resulting in adverse life events and\/or addictions. We endeavored to discover blood biomarkers for anxiety, using a four-step approach. First, we used a longitudinal within-subject design in individuals with psychiatric disorders to discover blood gene expression changes between self-reported low anxiety and high anxiety states. Second, we prioritized the list of candidate biomarkers with a Convergent Functional Genomics approach using other evidence in the field. Third, we validated our top biomarkers from discovery and prioritization in an independent cohort of psychiatric subjects with clinically severe anxiety. Fourth, we tested these candidate biomarkers for clinical utility, i.e. ability to predict anxiety severity state, and future clinical worsening (hospitalizations with anxiety as a contributory cause), in another independent cohort of psychiatric subjects. We showed increased accuracy of individual biomarkers with a personalized approach, by gender and diagnosis, particularly in women. The biomarkers with the best overall evidence were GAD1, NTRK3, ADRA2A, FZD10, GRK4, and SLC6A4. Finally, we identified which of our biomarkers are targets of existing drugs (such as a valproate, omega-3 fatty acids, fluoxetine, lithium, sertraline, benzodiazepines, and ketamine), and thus can be used to match patients to medications and measure response to treatment. We also used our biomarker gene expression signature to identify drugs that could be repurposed for treating anxiety, such as estradiol, pirenperone, loperamide, and disopyramide. Given the detrimental impact of untreated anxiety, the current lack of objective measures to guide treatment, and the addiction potential of existing benzodiazepines-based anxiety medications, there is a urgent need for more precise and personalized approaches like the one we developed.<\/jats:p>","DOI":"10.1038\/s41380-023-01998-0","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T02:02:32Z","timestamp":1678154552000},"page":"2894-2912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs"],"prefix":"10.1038","volume":"28","author":[{"given":"K.","family":"Roseberry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2530-5789","authenticated-orcid":false,"given":"H.","family":"Le-Niculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8431-9569","authenticated-orcid":false,"given":"D. F.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bhagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Soe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Palkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1586-2282","authenticated-orcid":false,"given":"W. A.","family":"Anastasiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8160-3839","authenticated-orcid":false,"given":"S. S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Niculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"1998_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41386-021-01183-3","volume":"47","author":"AB Niculescu","year":"2022","unstructured":"Niculescu AB, Le-Niculescu H. Precision medicine in psychiatry: biomarkers to the forefront. Neuropsychopharmacology. 2022;47:422\u20133.","journal-title":"Neuropsychopharmacology"},{"key":"1998_CR2","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41380-021-01061-w","volume":"26","author":"H Le-Niculescu","year":"2021","unstructured":"Le-Niculescu H, Roseberry K, Gill SS, Levey DF, Phalen PL, Mullen J, et al. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs. Mol Psychiatry. 2021;26:2776\u2013804.","journal-title":"Mol Psychiatry"},{"key":"1998_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.31887\/DCNS.2015.17.2\/proybyrne","volume":"17","author":"P Roy-Byrne","year":"2015","unstructured":"Roy-Byrne P. Treatment-refractory anxiety; definition, risk factors, and treatment challenges. Dialogues Clin Neurosci. 2015;17:191\u2013206.","journal-title":"Dialogues Clin Neurosci"},{"key":"1998_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/mp.2013.95","volume":"18","author":"H Le-Niculescu","year":"2013","unstructured":"Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, et al. Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry. 2013;18:1249\u201364.","journal-title":"Mol Psychiatry"},{"key":"1998_CR5","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/mp.2015.112","volume":"20","author":"AB Niculescu","year":"2015","unstructured":"Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol Psychiatry. 2015;20:1266\u201385.","journal-title":"Mol Psychiatry"},{"key":"1998_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/mp.2016.31","volume":"21","author":"DF Levey","year":"2016","unstructured":"Levey DF, Niculescu EM, Le-Niculescu H, Dainton HL, Phalen PL, Ladd TB, et al. Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment. Mol Psychiatry. 2016;21:768\u201385.","journal-title":"Mol Psychiatry"},{"key":"1998_CR7","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/mp.2017.128","volume":"22","author":"AB Niculescu","year":"2017","unstructured":"Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, et al. Precision medicine for suicidality: from universality to subtypes and personalization. Mol Psychiatry. 2017;22:1250\u201373.","journal-title":"Mol Psychiatry"},{"key":"1998_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.9","volume":"1","author":"H Le-Niculescu","year":"2011","unstructured":"Le-Niculescu H, Balaraman Y, Patel SD, Ayalew M, Gupta J, Kuczenski R, et al. Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Transl Psychiatry. 2011;1:e9.","journal-title":"Transl Psychiatry"},{"key":"1998_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.31887\/DCNS.2011.13.4\/nkoen","volume":"13","author":"N Koen","year":"2011","unstructured":"Koen N, Stein DJ. Pharmacotherapy of anxiety disorders: a critical review. Dialogues Clin Neurosci. 2011;13:423\u201337.","journal-title":"Dialogues Clin Neurosci"},{"key":"1998_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/sj.mp.4001845","volume":"11","author":"JM Hettema","year":"2006","unstructured":"Hettema JM, An SS, Neale MC, Bukszar J, van den Oord EJ, Kendler KS, et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry. 2006;11:752\u201362.","journal-title":"Mol Psychiatry"},{"key":"1998_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.pnpbp.2013.07.014","volume":"46","author":"K Domschke","year":"2013","unstructured":"Domschke K, Tidow N, Schrempf M, Schwarte K, Klauke B, Reif A, et al. Epigenetic signature of panic disorder: a role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation? Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:189\u201396.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1998_CR12","doi-asserted-by":"crossref","unstructured":"Wu H, Zhong Y, Xu H, Ding H, Yuan S, Wu Y, et al. Glutamic acid decarboxylase 1 gene methylation and panic disorder severity: making the connection by brain gray matter volume. Front Psychiatry 2022;13.","DOI":"10.3389\/fpsyt.2022.853613"},{"key":"1998_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/appi.ajp.2019.19030256","volume":"177","author":"DF Levey","year":"2020","unstructured":"Levey DF, Gelernter J, Polimanti R, Zhou H, Cheng Z, Aslan M, et al. Reproducible genetic risk loci for anxiety: results from approximately 200,000 participants in the million veteran program. Am J Psychiatry. 2020;177:223\u201332.","journal-title":"Am J Psychiatry"},{"key":"1998_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/archpsyc.62.6.603","volume":"62","author":"PS Wang","year":"2005","unstructured":"Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:603\u201313.","journal-title":"Arch Gen Psychiatry"},{"key":"1998_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2012.02.009","volume":"148","author":"R Chen","year":"2012","unstructured":"Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Miriami E, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148:1293\u2013307.","journal-title":"Cell"},{"key":"1998_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41380-018-0345-5","volume":"24","author":"AB Niculescu","year":"2019","unstructured":"Niculescu AB, Le-Niculescu H, Levey DF, Roseberry K, Soe KC, Rogers J, et al. Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs. Mol Psychiatry. 2019;24:501\u201322.","journal-title":"Mol Psychiatry"},{"key":"1998_CR17","doi-asserted-by":"crossref","unstructured":"Le-Niculescu H, Roseberry K, Levey DF, Rogers J, Kosary K, Prabha S, et al. Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs. Mol Psychiatry. 2020;25:918\u201338.","DOI":"10.1038\/s41380-019-0370-z"},{"key":"1998_CR18","doi-asserted-by":"crossref","unstructured":"Niculescu AB, Le-Niculescu H, Roseberry K, Wang S, Hart J, Kaur A, et al. Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs. Mol Psychiatry. 2020;25:1651\u201372.","DOI":"10.1038\/s41380-019-0602-2"},{"key":"1998_CR19","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41380-019-0559-1","volume":"25","author":"KL Purves","year":"2020","unstructured":"Purves KL, Coleman JRI, Meier SM, Rayner C, Davis KAS, Cheesman R, et al. A major role for common genetic variation in anxiety disorders. Mol Psychiatry. 2020;25:3292\u2013303.","journal-title":"Mol Psychiatry"},{"key":"1998_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41386-020-00900-8","volume":"46","author":"NP Daskalakis","year":"2021","unstructured":"Daskalakis NP, Xu C, Bader HN, Chatzinakos C, Weber P, Makotkine I, et al. Intergenerational trauma is associated with expression alterations in glucocorticoid- and immune-related genes. Neuropsychopharmacology. 2021;46:763\u201373.","journal-title":"Neuropsychopharmacology"},{"key":"1998_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1124\/mol.105.011809","volume":"68","author":"V Pascoli","year":"2005","unstructured":"Pascoli V, Valjent E, Corbille AG, Corvol JC, Tassin JP, Girault JA, et al. cAMP and extracellular signal-regulated kinase signaling in response to d-amphetamine and methylphenidate in the prefrontal cortex in vivo: role of beta 1-adrenoceptors. Mol Pharm. 2005;68:421\u20139.","journal-title":"Mol Pharm"},{"key":"1998_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fnbeh.2016.00136","volume":"10","author":"CH Choi","year":"2016","unstructured":"Choi CH, Schoenfeld BP, Bell AJ, Hinchey J, Rosenfelt C, Gertner MJ, et al. Multiple drug treatments that increase camp signaling restore long-term memory and aberrant signaling in fragile X syndrome models. Front Behav Neurosci. 2016;10:136.","journal-title":"Front Behav Neurosci"},{"key":"1998_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3389\/fpsyt.2018.00715","volume":"9","author":"J Stepan","year":"2018","unstructured":"Stepan J, Anderzhanova E, Gassen NC. Hippo signaling: emerging pathway in stress-related psychiatric disorders? Front Psychiatry. 2018;9:715.","journal-title":"Front Psychiatry"},{"key":"1998_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0206-7","volume":"8","author":"DR Bach","year":"2018","unstructured":"Bach DR, Korn CW, Vunder J, Bantel A. Effect of valproate and pregabalin on human anxiety-like behaviour in a randomised controlled trial. Transl Psychiatry. 2018;8:157.","journal-title":"Transl Psychiatry"},{"key":"1998_CR25","doi-asserted-by":"publisher","first-page":"105851","DOI":"10.1016\/j.psyneuen.2022.105851","volume":"143","author":"S Lozza-Fiacco","year":"2022","unstructured":"Lozza-Fiacco S, Gordon JL, Andersen EH, Kozik RG, Neely O, Schiller C, et al. Baseline anxiety-sensitivity to estradiol fluctuations predicts anxiety symptom response to transdermal estradiol treatment in perimenopausal women - a randomized clinical trial. Psychoneuroendocrinology. 2022;143:105851.","journal-title":"Psychoneuroendocrinology"},{"key":"1998_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","volume":"17","author":"B Bandelow","year":"2015","unstructured":"Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17:327\u201335.","journal-title":"Dialogues Clin Neurosci"},{"key":"1998_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00127-021-02122-9","volume":"57","author":"KB Parodi","year":"2022","unstructured":"Parodi KB, Holt MK, Green JG, Porche MV, Koenig B, Xuan Z. Time trends and disparities in anxiety among adolescents, 2012\u20132018. Soc Psychiatry Psychiatr Epidemiol. 2022;57:127\u201337.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"1998_CR28","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313:1929\u201335.","journal-title":"Science"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01998-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01998-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01998-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T03:12:07Z","timestamp":1698721927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01998-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1998"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-01998-0","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ABN is listed as an inventor on a patent application filed by Indiana University. ABN and AS are co-founders, SMK is a consultant, and SG is a part-time employee of MindX Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}